Considering the effect of SOST on breast cancer cell proliferation and the presence of SOST in the cytoplasm, we speculate that SOST may activate the RAS and TGF-β signaling pathways by interacting with intracytoplasmic transcription factors, such as STAT3. The gene discussed is SOST; the disease is breast carcinoma.